HomeOwner SearchCategory Search
Visit USCOEmerging Therapies In Psoriasis [Published: 2021-01-01. Issue: January 2021]
Serial Registration
Copyright Title
Emerging Therapies In Psoriasis [Published: 2021-01-01. Issue: January 2021]
Status
Published
on 19 Jan 2021
Year of Creation
2021
Copyright Claimant
Matrix Medical Communications
Registration Number
TX0008937136
on 19 Jan 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008937136) dated 19 Jan 2021, pertains to an electronic file (eService) titled "Emerging Therapies In Psoriasis [Published: 2021-01-01. Issue: January 2021]" created in 2021. The copyright holder is Matrix Medical Communications, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Matrix Medical Communications.
Application Details
Registration Number
TX0008937136
Registration Date
1/19/2021
Year of Creation
2021
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Matrix Medical Communications
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Matrix Medical Communications, 1595 Paoli Pike, Suite 201, West Chester, PA, 19380, United States, (484) 266-0702, shenne@matrixmedcom.com
Copyright Local Holdings: January 2021 Created 2021 Pub. 2021-01-01 Reg. 2021-01-19 TX0008937136 SLEF
Statements
Application Title Statement: Emerging Therapies In Psoriasis
Author Statement: Matrix Medical Communications employer for hire Domicile: United States Citizenship: United States Authorship: Collective Work Authorship
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.